预先选择的,多样化的 Maybridge HitFinder 筛选库使识别潜在的药物线索变得容易, 方便,成本效益高。预制集合 由14,400个 Maybridge 筛选化合物组成。预先选择的,多样化的Maybridge HitFinder 筛选库使识别潜在的药物线索变得容易, 方便,成本效益高。预制的库由14,400个Maybridge 筛选化合物组成,选择使用基于standard Daylight fingerprints 和Tanimoto 相似性的聚类算法来代表Maybridge 筛选集合的多样性。HitFinder 系列包括14,400种化合物,代表了Maybridge 筛选系列的药物多样性,提供简单快速的先导鉴定。 使用聚类算法进行选择,采用standard Daylight fingerprints,Tanimoto 相似指数聚类相似度为0.71。所有筛选的化合物都符合Lipinski“药物相似”准则,而且纯度都大于90%。化合物被选择为非反应性的,有助于确保更少的假阳性和更高质量的结果。当您准备优化您的药物先导时,我们超过6000种先进的,新颖的Maybridge 构建模块可提供高化学多样性,以加速您的药物设计过程。
The pre-selected, diverse Maybridge HitFinder screening library makes identifying potential drug leads easy, convenient, and cost-effective. The pre-plated collection consists of 14,400 Maybridge screening compounds, selected to represent the diversity of the Maybridge screening collection using a clustering algorithm based on standard Daylight fingerprints and Tanimoto similarity. The HitFinder collection comprises 14,400 compounds representing the drug-like diversity of the Maybridge screening collection, offering easy and rapid lead identification.
Selections are made using a clustering algorithm employing standard Daylight fingerprints with the Tanimoto similarity index clustering at 0.71 similarities. All screening compounds fit Lipinski’s guidelines for ""drug-likeness,"" and all have purity greater than 90%.Compounds have been selected to be non-reactive, helping to ensure fewer false positives and higher quality results. When you are ready to optimize your drug lead, our range of over 6,000 advanced, novel Maybridge building blocks provides high chemical diversity for accelerating your drug design process.